Regulacje i polityka gospodarcza · 28.11.2025
CMS Announces Final Guidance for Medicare Drug Price Negotiation Program
The Centers for Medicare & Medicaid Services (CMS) has released final guidance for the Medicare Drug Price Negotiation Program, set to begin in 2026, as part of the Inflation Reduction Act of 2022 (IRA).